David A. Perrey

446 total citations
21 papers, 374 citations indexed

About

David A. Perrey is a scholar working on Cognitive Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, David A. Perrey has authored 21 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cognitive Neuroscience, 8 papers in Molecular Biology and 8 papers in Endocrine and Autonomic Systems. Recurrent topics in David A. Perrey's work include Sleep and Wakefulness Research (9 papers), Sleep and related disorders (6 papers) and Circadian rhythm and melatonin (6 papers). David A. Perrey is often cited by papers focused on Sleep and Wakefulness Research (9 papers), Sleep and related disorders (6 papers) and Circadian rhythm and melatonin (6 papers). David A. Perrey collaborates with scholars based in United States, France and United Kingdom. David A. Perrey's co-authors include Yanan Zhang, Brian P. Gilmour, Brian F. Thomas, Fatih M. Uckun, Danni L. Harris, Ann M. Decker, Jun‐Xu Li, Scott P. Runyon, Nadezhda German and Chris M. Brown and has published in prestigious journals such as Brain Research, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

David A. Perrey

20 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Perrey United States 13 142 130 113 110 105 21 374
Luigi Stasi Italy 11 46 0.3× 128 1.0× 118 1.0× 62 0.6× 31 0.3× 20 325
Steven Coulton United Kingdom 14 117 0.8× 307 2.4× 204 1.8× 98 0.9× 88 0.8× 32 635
Thierry Sifferlen Switzerland 15 159 1.1× 291 2.2× 289 2.6× 122 1.1× 136 1.3× 29 581
John D. Schreier United States 9 128 0.9× 135 1.0× 131 1.2× 108 1.0× 107 1.0× 10 377
Bradley R. Teegarden United States 9 41 0.3× 171 1.3× 162 1.4× 24 0.2× 36 0.3× 11 348
Masahito Abe Japan 12 56 0.4× 98 0.8× 168 1.5× 26 0.2× 40 0.4× 18 358
Benjamin L. Adams United States 8 71 0.5× 37 0.3× 125 1.1× 62 0.6× 45 0.4× 13 276
Lesley A. Howell United Kingdom 15 45 0.3× 82 0.6× 347 3.1× 51 0.5× 23 0.2× 27 566
Dirk Behnke Germany 9 132 0.9× 117 0.9× 65 0.6× 103 0.9× 115 1.1× 12 270
Hamed Aissaoui Switzerland 14 555 3.9× 84 0.6× 99 0.9× 484 4.4× 476 4.5× 20 807

Countries citing papers authored by David A. Perrey

Since Specialization
Citations

This map shows the geographic impact of David A. Perrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Perrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Perrey more than expected).

Fields of papers citing papers by David A. Perrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Perrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Perrey. The network helps show where David A. Perrey may publish in the future.

Co-authorship network of co-authors of David A. Perrey

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Perrey. A scholar is included among the top collaborators of David A. Perrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Perrey. David A. Perrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahman, Md Toufiqur, Ann M. Decker, Sami Ben Hamida, et al.. (2023). Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation. Journal of Medicinal Chemistry. 66(4). 2964–2978. 7 indexed citations
2.
Zhang, Dehui�, David A. Perrey, Ann M. Decker, et al.. (2021). Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists. Journal of Medicinal Chemistry. 64(12). 8806–8825. 19 indexed citations
3.
Ding, Huiping, Norikazu Kiguchi, David A. Perrey, et al.. (2020). Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates. British Journal of Anaesthesia. 125(4). 596–604. 27 indexed citations
4.
Perrey, David A., Dehui� Zhang, Thuy Nguyen, et al.. (2018). Synthesis of Enantiopure PZM21: A Biased Agonist of the Mu‐Opioid Receptor. European Journal of Organic Chemistry. 2018(29). 4006–4012. 3 indexed citations
5.
Perrey, David A. & Yanan Zhang. (2018). Therapeutics development for addiction: Orexin-1 receptor antagonists. Brain Research. 1731. 145922–145922. 48 indexed citations
6.
Ding, Huiping, Norikazu Kiguchi, David A. Perrey, et al.. (2018). Reinforcing, Antinociceptive, and Pruritic Effects of a G Protein‐Biased Mu Opioid Receptor Agonist, PZM21, in Primates. The FASEB Journal. 32(S1). 1 indexed citations
7.
Brodnik, Zachary D., et al.. (2017). Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling. Psychopharmacology. 234(18). 2761–2776. 28 indexed citations
8.
Perrey, David A., Ann M. Decker, & Yanan Zhang. (2017). Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability. ACS Chemical Neuroscience. 9(3). 587–602. 10 indexed citations
9.
Zhang, Yanan, David A. Perrey, & Jun‐Xu Li. (2016). Modified Synthesis of NOP Receptor Antagonist SB612111. Synthesis. 49(6). 1394–1400. 3 indexed citations
10.
Perrey, David A., Ann M. Decker, Jun‐Xu Li, et al.. (2015). The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorganic & Medicinal Chemistry. 23(17). 5709–5724. 16 indexed citations
11.
Perrey, David A., Nadezhda German, Ann M. Decker, et al.. (2015). Effect of 1-Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin-1 Receptor. ACS Chemical Neuroscience. 6(4). 599–614. 13 indexed citations
12.
Perrey, David A., Brian P. Gilmour, Brian F. Thomas, & Yanan Zhang. (2014). Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers. ACS Medicinal Chemistry Letters. 5(6). 634–638. 25 indexed citations
13.
Perrey, David A., Brian P. Gilmour, Scott P. Runyon, Brian F. Thomas, & Yanan Zhang. (2011). Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(10). 2980–2985. 16 indexed citations
14.
Dennis, Richard, Shuliang Lee, Gilles Ouvry, et al.. (2007). Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II. European Journal of Medicinal Chemistry. 43(6). 1123–1151. 35 indexed citations
15.
Dennis, Richard, Shuliang Lee, David A. Perrey, et al.. (2007). Synthesis and biological activity of imidazopyridine anticoccidial agents: Part I. European Journal of Medicinal Chemistry. 42(11-12). 1334–1357. 45 indexed citations
16.
Perrey, David A., et al.. (2002). A Degradation Study of a Series of Chloromethyl and Diazomethyl Ketone Anti-leukemic Agents. Drug Development and Industrial Pharmacy. 28(2). 143–149.
17.
Perrey, David A. & Fatih M. Uckun. (2001). An improved method for cysteine alkylation. Tetrahedron Letters. 42(10). 1859–1861. 13 indexed citations
18.
Perrey, David A., et al.. (2000). The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds. Bioorganic & Medicinal Chemistry Letters. 10(6). 551–552. 8 indexed citations
19.
Perrey, David A., Rama Krishna Narla, & Fatih M. Uckun. (2000). Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity. Bioorganic & Medicinal Chemistry Letters. 10(6). 547–549. 9 indexed citations
20.
Camp, Nicholas P., David A. Perrey, Derek Kinchington, Paul C. D. Hawkins, & David Gani. (1995). Synthesis of peptide analogues containing phosphonamidate methyl ester functionality: HIV-1 proteinase inhibitors possessing unique cell uptake properties. Bioorganic & Medicinal Chemistry. 3(3). 297–312. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Stasi Breakdown of academic impact, for papers by Steven Coulton Breakdown of academic impact, for papers by Thierry Sifferlen Breakdown of academic impact, for papers by John D. Schreier Breakdown of academic impact, for papers by Bradley R. Teegarden Breakdown of academic impact, for papers by Masahito Abe Breakdown of academic impact, for papers by Benjamin L. Adams Breakdown of academic impact, for papers by Lesley A. Howell Breakdown of academic impact, for papers by Dirk Behnke Breakdown of academic impact, for papers by Hamed Aissaoui
Rankless by CCL
2026